GE HealthCare Technologies (GEHC) Long-Term Debt Issuances (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Long-Term Debt Issuances came in at $1.2 billion in Q1 2026, down 7.1% on a QoQ basis from $1.2 billion in Q4 2025.
GE HealthCare Technologies (GEHC) Long-Term Debt Issuances (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Long-Term Debt Issuances data on file, last reported at $1.2 billion in Q1 2026.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Jun 2026 was $2.4 billion (down 3.78% YoY) and the FY2025 annual result came in at $2.7 billion, up 174.77% from the prior year.
- Long-Term Debt Issuances eased to $1.2 billion in Q1 2026, from $1.2 billion in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $8.2 billion in Q4 2022 to a low of -$14.0 million in Q4 2023.
- A 5-year average of $1.3 billion and a median of $506.5 million in 2023 frame the typical range for Long-Term Debt Issuances.
- Annual changes were most pronounced in 2023 — Long-Term Debt Issuances tumbled 100.17% — and 2025, when it jumped 123900.0%.
- Tracing GEHC's Long-Term Debt Issuances over 5 years: stood at $8.2 billion in 2022, then plunged by 100.17% to -$14.0 million in 2023, then jumped by 107.14% to $1.0 million in 2024, then jumped by 123900.0% to $1.2 billion in 2025, then dropped by 7.1% to $1.2 billion in 2026.
- The last three Long-Term Debt Issuances figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -33.00 Mn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 109.26 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Bn |
| Mar 31, 2026 | 1.15 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Dec 31, 2025 | 1.24 Bn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.49 Bn |
| Jun 30, 2025 | 1.49 Bn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 993.00 Mn |
| Sep 30, 2024 | 993.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Dec 31, 2023 | -14.00 Mn |
| Sep 30, 2023 | 20.00 Mn |
| Sep 30, 2023 | 20.00 Mn |
| Mar 31, 2023 | 2.00 Bn |
| Mar 31, 2023 | 2.00 Bn |